Recent news on Vivitrol

Positive Information About VIVITROL For Treatment Of Alcoholism ...  -  May 16, 2007
eMaxHealth.com,Substance Abuse and Mental Health Services Administration features a comprehensive overview of VIVITROL (naltrexone for extended- release injectable

US Government Organizations Release Positive Information About ...  -  May 16, 2007
Medical News Today (press release),The advisory features a comprehensive overview of VIVITROL(R) (naltrexone for extended- release injectable suspension), the first and only once-monthly

US Government Organizations Release Positive Information About ...  -  May 15, 2007
PR Newswire (press release),Substance Abuse and Mental Health Services Administration and National Institute on Alcohol Abuse and Alcoholism Feature VIVITROL in Recent Publications

US Government Organizations Release Positive Information About ...  -  May 15, 2007
StreetInsider.com (subscription),The Guide was recently updated to include information about VIVITROL as the most recently FDA-approved medication for the treatment of alcohol dependence.

Shot of Vivitrol cuts alcohol cravings for some addicts  -  Apr 25, 2007
Houston Chronicle,Approved by the federal Food and Drug Administration in April 2006, Vivitrol is an injectable version of an oral medication — naltrexone — which has been

Market Report -- In Play (CEPH)  -  May 15, 2007
MSN MoneyCephalon: US Government Organizations release "positive information" about VIVITROL for the treatment of alcoholism Co notes The Substance Abuse and Mental

Dr. Gott:: Medicine gives new hope to alcoholics  -  May 5, 2007
The Spokesman Review,...reported on the results of a study that tested the effectiveness of a monthly injection of Vivitrol (naltrexone) in more than 600 recovering alcoholics.

Robert W. Baird Growth Stock Conference to Webcast Alkermes ...  -  May 4, 2007
PharmaLive.com (press release),...and VIVITROL(R) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment

Cephalon First Quarter Earnings Increase Dramatically  -  May 1, 2007
PR Newswire (press release),TRISENOX(R), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), ACTIQ(R) (oral transmucosal

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  Apr 25, 2007
PR-Inside.com (Pressemitteilung),GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) (naltrexone for extended-release injectable suspension)

Shot of Vivitrol cuts alcohol cravings for some addicts  -  26 Apr 2007
Houston Chronicle,Approved by the federal Food and Drug Administration in April 2006, Vivitrol is an injectable version of an oral medication — naltrexone — which has been

Alkermes and Indevus Announce Initiation of Phase 2a Clinical ...  -  26 Apr 2007
PipelineReview.com (press release),AIR(R) is a registered trademark of Alkermes, Inc; VIVITROL(R) is a registered trademark of Cephalon, Inc.; and RISPERDAL(R) CONSTA(R) is a registered

US PSYCH: Atypical Antipsychotic Medication Cuts Behavioral ...  -  26 Apr 2007
Psychiatric Times,...clinicians have tried a laundry list of medications ranging from stimulants to anticonvulsants to the substance abuse drug naltrexone (Vivitrol).

Cephalon Expects First Quarter 2007 Results to Exceed Expectations  -  26 Apr 2007
MSN MoneyGABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) (naltrexone for extended-release injectable suspension)

Alkermes Submits Marketing Authorization Application for Vivitrol ...  -  Apr 2, 2007
Genetic Engineering News (press release),VIVITROL, the first and only once-monthly treatment for alcohol dependence, was approved by the US Food and Drug Administration (FDA) in April 2006.

Alkermes Seeks UK, German Vivitrol OK  -  Apr 2, 2007
Forbes,Biotechnology company Alkermes Inc. said Monday it asked UK and German regulators to approve its extended-release Vivitrol to treat alcohol dependence.

Market Report -- In Play (ALKS)  -  Apr 2, 2007
MSN MoneyAlkermes submits Marketing Authorization Application for Vivitrol in the United Kingdom and Germany Co announced that it has submitted a Marketing

FDA Approves New Dose Of RISPERDAL® CONSTA® For Schizophrenia ...  -  Apr 16, 2007
Medical News Today (press release),...a wholly owned division of Johnson & Johnson; and VIVITROL® (naltrexone for extended- release injectable suspension) the first and only once-monthly

FDA Approves New Dose of RISPERDAL(R) CONSTA(R) for Schizophrenia ...  -  Apr 14, 2007
PipelineReview.com (press release),...and VIVITROL(R) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment

Biotech Day In Review: Roche Picks Up Antibody Firm For $56.5 Million  -  Apr 3, 2007
Seeking Alpha,Alkermes (ALKS) asked for approval of Vivitrol, a one-month injectable drug for alcohol dependence, in the UK and Germany. It was approved in the US in

Cephalon Provides Update Related to NUVIGIL(TM) New Drug Application  -  Apr 3, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) (naltrexone for extended-release injectable suspension)

Cephalon Files Marketing Application for Approval of a Fentanyl ...  -  Mar 29, 2007
Drug Newswire (press release),The company's products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA, TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R)

Cephalon Files Marketing Application For Approval Of A Fentanyl ...  -  27 Mar 2007
Medical News Today (press release),The company's products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA, TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R)

Science of sober  -  Mar 26, 2007
Indianapolis Star,And last year, the FDA approved an extended form of naltrexone, a once-monthly injection under the brand name Vivitrol, made by Alkermes Inc.

Addiction Medicine Associates Provides Novel Treatment Option for ...  -  Mar 12, 2007
Business Wire (press release),Vivitrol, which is used in addition to counseling, is the first ever once-a-month injectable medication for alcoholism. Its novel delivery system helps

Alkermes treatment to be used on Mass. patients  -  Mar 13, 2007
Bizjournals.com,...based outpatient substance dependence treatment provider, said Monday the naltrexone medication, known commercially as Vivitrol, will be used in combination

Zacks Analyst Interview Highlights: Alkermes, Johnson & Johnson ...  -  Mar 13, 2007
Business Wire (press release),The company has two approved products on the market: Risperdal Consta for schizophrenia and Vivitrol for alcoholism. Alkermes has a strong alliance with

Alcoholism drug gets a boost  -  Mar 12, 2007
Boston Globe,Addiction Medicine Associates said today will offer Vivitrol as an option to treat alcohol dependence at some of its locations.

Alkermes Announces Senior Management Succession Plan  -  Mar 5, 2007
PharmaLive.com (press release),..."We are now a profitable biotechnology company with two breakthrough drugs on the market, RISPERDAL CONSTA and VIVITROL, a strong program in diabetes with

Pops to go from Alkermes chief to chairman  -  Mar 6, 2007
Boston Globe,After 18 years of losing money, Alkermes recorded its first profit last year, and introduced a new product: Vivitrol , a monthly injection to treat

Alkermes Names New CEO  -  Mar 5, 2007
TheStreet.comAlkermes also developed Vivitrol, an injectable version of the generic drug naltrexone, which is used in treating alcoholism. Vivitrol is administered once

Cowen and Co. Annual Health Care Conference to Webcast Alkermes ...  -  Mar 9, 2007
PharmaLive.com (press release),...and VIVITROL(R) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment

Cowen and Co. Annual Health Care Conference to Webcast Alkermes ...  -  Mar 8, 2007
Business Wire (press release),...a wholly owned division of Johnson & Johnson; and VIVITROL ® (naltrexone for extended-release injectable suspension) the first and only once-monthly

Alkermes names new CEO  -  Mar 5, 2007
Bizjournals.com,Alkermes (Nasdaq: ALKS) currently has two commercial products; Risperdal Consta, a long-acting injection for the treatment of schizophrenia and Vivitrol,

Alkermes Completes Patient Enrollment for Phase 1/2 Study of ALKS ...  -  Mar 7, 2007
PipelineReview.com (press release),VIVITROL® is a registered trademark of Cephalon, Inc.; RISPERDAL® CONSTA® is a registered trademark of Johnson & Johnson Corporation.

Alkermes Completes Patient Enrollment for Phase 1/2 Study of ALKS ...  -  Mar 6, 2007
PharmaLive.com (press release),VIVITROL(R) is a registered trademark of Cephalon, Inc.; RISPERDAL(R) CONSTA(R) is a registered trademark of Johnson & Johnson Corporation.

Alkermes Announces Third Quarter Fiscal 2007 Results  -  Feb 8, 2007
PharmaLive.com (press release),While Alkermes does not record VIVITROL sales, the Company expects sales of VIVITROL in fiscal 2007 to remain in the range of $5 to $10 million.

Outlook Improves at Alkermes  -  Feb 8, 2007
TheStreet.com31, Alkermes overcame continuing disappointing sales of the Vivitrol alcoholism treatment with a big improvement for its Risperdal Consta schizophrenia

Cephalon's Supercharged Growth  -  Feb 16, 2007
Motley FoolAlcohol-dependence treatment Vivitrol appears to be a big flop, with partner Alkermes (Nasdaq: ALKS) only projecting $5 million-$10 million in sales this

BIO CEO and Investor Conference to Webcast Alkermes' Corporate ...  -  Feb 9, 2007
PharmaLive.com (press release),...and VIVITROL(R) (naltrexone for extended-release injectable suspension) the first and only once-monthly injectable medication approved for the treatment

BIO CEO and Investor Conference to Webcast Alkermes’ Corporate ...  -  Feb 8, 2007
Business Wire (press release),...a wholly owned division of Johnson & Johnson; and VIVITROL ® (naltrexone for extended-release injectable suspension) the first and only once-monthly

Alkermes Raises 2007 Forecasts  -  Feb 7, 2007
Forbes,Those revisions are due to higher expectations for Risperdal and Vivitrol sales. Royalty revenue from Risperdal remains in the range of $21 million to $23

Alkermes 3Q Profit Doubles  -  Feb 7, 2007
Forbes,The revenue boost during the quarter came mainly from the manufacturing of Risperdal Consta and Vivitrol for Janssen-Cilag. As of Dec.

Alkermes raises revenue and profit forecast for fiscal 2007  -  Feb 7, 2007
Eyewitness News,...up from earlier expectations of between 85-and-95 (m) million dollars. Those revisions are due to higher expectations for Risperdal and Vivitrol sales.

Riddle of addiction lures researchers  -  Feb 11, 2007
San Francisco Chronicle,In a six-month clinical trial published last year, alcoholics on Vivitrol dropped from 19 "heavy drinking days" a month to about three.

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 12, 2007
MSN MoneyIn 2005, to exclude the write-off of acquired in-process research and development related to the acquisition of Salmedix ($130.1 million), VIVITROL product

Cephalon Reports Record Sales and Earnings for 2006  -  Feb 15, 2007
Drug Newswire (press release),FENTORA(TM) (fentanyl buccal tablet) [C-II], TRISENOX(R) (arsenic trioxide), VIVITROL(R) (naltrexone for extended-release injectable suspension),

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 12, 2007
Drug Newswire (press release),GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) (naltrexone for extended-release injectable suspension)

Akamai revenue rises 52 percent  -  Feb 7, 2007
Boston Globe,The revenue boost during the quarter was mainly from the manufacturing of Risperdal Consta and Vivitrol for Janssen-Cilag.

Cephalon, Inc. Promotes Mike Barr to Vice President  -  Feb 7, 2007
Yahoo! News (press release)GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic trioxide) injection, and VIVITROL® (naltrexone for extended-release injectable suspension).

Alcohol Dependence Patterns and Their Impact on New York City  -  Feb 2, 2007
Medscape (subscription)Alkermes and Cephalon receive FDA approval of Vivitrol for the treatment of alcohol dependence [press release]. Frazer, Pa: Cephalon, Inc; April 13, 2006.

Alkermes to Host Conference Call to Discuss Financial Results for ...  -  Feb 1, 2007
PharmaLive.com (press release),...a wholly owned division of Johnson & Johnson; and VIVITROL(R) (naltrexone for extended-release injectable suspension), the first and only once-monthly

Alkermes to Host Conference Call to Discuss Financial Results for ...  -  Jan 31, 2007
Business Wire (press release),...and VIVITROL ® (naltrexone for extended-release injectable suspension), the first and only once-monthly injectable medication approved for the treatment

St. Louis Woman Alcohol-Free On New Year's For First Time In 30 Years  -  Dec 29, 2006
KSDK,Five months ago, Parmentar started a new treatment that involved monthly injections of the drug Vivitrol combined with counseling.

Alkermes' Japanese Opportunity  -  Dec 27, 2006
Motley FoolVivitrol, though, is getting off to a very slow start with only $10 million in fiscal 2007 sales expected at most. The drug may not be the hit that Alkermes

JPMorgan Annual Healthcare Conference to Webcast Alkermes ...  -  Jan 3, 2007
PharmaLive.com (press release),VIVITROL(R) is a registered trademark of Cephalon, Inc. and RISPERDAL(R) CONSTA(R) is a registered trademark of Johnson & Johnson Corporation.

Zacks Analyst Blog Highlights: Alkermes and Campbell Soup  -  Jan 8, 2007
Black Enterprise,We are optimistic about a number of mid- to late-stage candidates and the recent launch of Vivitrol. We expect to see strong top-line growth in the coming

Rensselaer Team Develops Novel Opioid Receptor Compounds  -  Jan 10, 2007
Rensselaer Polytechnic Institute,...which provides us with the opportunity to leverage our success and experience with VIVITROL and build our proprietary product portfolio.�

Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration  -  Jan 8, 2007
Genetic Engineering News (press release),AIR(R) is a registered trademark of Alkermes, Inc. and VIVITROL(R) is a registered trademark of Cephalon, Inc.

Alkermes and Indevus Announce Joint Collaboration to Develop ...  -  Jan 5, 2007
PipelineReview.com (press release),AIR® is a registered trademark of Alkermes, Inc; VIVITROL® is a registered trademark of Cephalon, Inc.; SANCTURA® is a registered trademark of Indevus

Alkermes and Indevus Announce Joint Collaboration to Develop ...  -  Jan 4, 2007
PharmaLive.com (press release),AIR(R) is a registered trademark of Alkermes, Inc; VIVITROL(R) is a registered trademark of Cephalon, Inc.; SANCTURA(R) is a registered trademark of Indevus

Catalyst focuses on drug to treat addicts  -  Jan 14, 2007
Miami Herald,Vivitrol is under development to treat alcohol dependence. Acomplia, already on the market in Europe, blocks receptors that govern food intake and tobacco

Alkermes Announces Submission of New Drug Application for ...  -  Dec 20, 2006
PharmaLive.com (press release),Medisorb(R) is a trademark of Alkermes, Inc., VIVITROL(R) is a trademark of Cephalon, Inc. and RISPERDAL(R) CONSTA(R) is a registered trademark of Johnson

Alkermes Announces Submission of New Drug Application for ...  -  Dec 20, 2006
Business Wire (press release),Medisorb ® is a trademark of Alkermes, Inc., VIVITROL ® is a trademark of Cephalon, Inc. and RISPERDAL ® CONSTA ® is a registered trademark of Johnson

Cephalon Announces Positive Results from Two Phase 3 Clinical ...  -  Jan 9, 2007
Yahoo! News (press release)FENTORA, TRISENOX® (arsenic trioxide) injection, VIVITROL® (naltrexone for extended-release injectable suspension), GABITRIL® (tiagabine hydrochloride),

Cephalon Announces Positive Results from Two Phase 3 Clinical ...  -  Jan 9, 2007
PR Newswire (press release),TRISENOX(R) (arsenic trioxide) injection, VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride),

Alkermes and Lilly Expand AIR(R) Inhaled Insulin Collaboration  -  Jan 9, 2007
PipelineReview.com (press release),...and VIVITROL® (naltrexone for extended-release injectable suspension), the first and only once-monthly injectable medication approved for the treatment

This year, a plan for sobriety  -  Jan 7, 2007
Los Angeles Times,Among the newer treatments is Vivitrol, approved by the Food and Drug Administration last April. A monthly injection version of the oral alcoholism drug

2006 in Review: Cephalon  -  Dec 29, 2006
Motley FoolIn the second quarter, Cephalon and partner Alkermes (Nasdaq: ALKS) received marketing approval in the US for their alcohol-dependence drug, Vivitrol.

Assisted Recovery Centers of America Offers New Treatment Options ...  -  Dec 11, 2006
Primenewswire (press release),ARCA is one of the first facilities in St. Louis to now offer VIVITROL(r), an extended-release injectable form of naltrexone, to treat alcohol dependence. ...

Almost 108 Million Prevalent Cases of Nicotine and Alcohol ...  -  Dec 18, 2006
Earthtimes.org...smoking cessation, Nabi Biopharmaceuticals' NicVAX for nicotine addiction, and Alkermes/Cephalon's high-priced, once- monthly, injectable Vivitrol for alcohol ...

Alkermes Announces Submission of New Drug Application for ...  -  Dec 20, 2006
Genetic Engineering News (press release),...approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL(R) (naltrexone ...

Expectations Deflated for Alkermes  -  Dec 1, 2006
TheStreet.com (subscription),Earlier in the year, the company had been riding high on the prospects for its new alcoholism treatment, Vivitrol, and a generous co-promotion deal with ...

Alkermes says study shows promise for drug addiction treatment  -  Dec 4, 2006
Boston Business Journal,The medication, known under the product name Vivitrol, was developed with Cephalon Inc. ... While ReVia works similarly to Vivitrol, it must be taken daily. ...

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
Yahoo! News (press release)...oral transmucosal fentanyl citrate) [C-II], GABITRIL® (tiagabine hydrochloride), TRISENOX® (arsenic trioxide) injection, and VIVITROL® (naltrexone for ...

Cephalon Reduces Outstanding Convertible Debt by $337 Million  -  Dec 19, 2006
PharmaLive.com (press release),R) (oral transmucosal fentanyl citrate) [C-II], GABITRIL(R) (tiagabine hydrochloride), TRISENOX(R) (arsenic trioxide) injection, and VIVITROL(R) (naltrexone ...

Want a healthier life? Be a quitter  -  Dec 15, 2006
Sacramento Bee,Naltrexone can reduce the craving for alcohol. A recently approved injectable form of the drug (called Vivitrol) can be used once a month. ...

The NASDAQ Investor Program to Webcast Alkermes’ Corporate ...  -  Dec 4, 2006
Business Wire (press release),...approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson & Johnson; and VIVITROL R (naltrexone ...

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional